美国 · SEC FORM 4
Sight Sciences, Inc.
SGHT · Nasdaq · CIK 0001531177 · Healthcare · Medical Devices
内部人信号
1 qualifying P purchase group
当前 180 天评分窗口
19 同一窗口内观察到的 Form 4 交易行
12 sales · 6 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
买方广度与集中度
Roles in the peak window: Director,TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-06-10 · Encrantz Staffan.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 1,416,320
- 上期报告
- 1,252,772
- 日均成交量
- 343,089
- 回补天数
- 4.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-10 | Encrantz Staffan | 买入 (P) | Common Stock | 14,100 | USD 4.88 | USD 68,808 | SEC 申报 ↗ |
| 2025-12-16 | Encrantz Staffan | 买入 (P) | Common Stock | 13,958 | USD 8.31 | USD 115,991 | SEC 申报 ↗ |
| 2025-06-06 | Encrantz Staffan | 买入 (P) | Common Stock | 27,900 | USD 4.22 | USD 117,738 | SEC 申报 ↗ |
| 2025-06-05 | Encrantz Staffan | 买入 (P) | Common Stock | 40,951 | USD 4.24 | USD 173,632 | SEC 申报 ↗ |
| 2025-06-04 | Encrantz Staffan | 买入 (P) | Common Stock | 21,674 | USD 4.17 | USD 90,381 | SEC 申报 ↗ |
| 2025-06-03 | Encrantz Staffan | 买入 (P) | Common Stock | 25,230 | USD 3.97 | USD 100,163 | SEC 申报 ↗ |
| 2025-06-02 | Encrantz Staffan | 买入 (P) | Common Stock | 30,799 | USD 3.88 | USD 119,500 | SEC 申报 ↗ |
| 2025-05-30 | Encrantz Staffan | 买入 (P) | Common Stock | 42,753 | USD 3.67 | USD 156,904 | SEC 申报 ↗ |
| 2025-05-29 | Encrantz Staffan | 买入 (P) | Common Stock | 60,128 | USD 3.59 | USD 215,860 | SEC 申报 ↗ |
| 2025-05-28 | Encrantz Staffan | 买入 (P) | Common Stock | 26,715 | USD 3.52 | USD 94,037 | SEC 申报 ↗ |
| 2025-05-27 | Encrantz Staffan | 买入 (P) | Common Stock | 41,346 | USD 3.44 | USD 142,230 | SEC 申报 ↗ |
| 2025-03-13 | Raheja Manohar K. | 买入 (P) | Common Stock | 10,000 | USD 2.60 | USD 26,000 | SEC 申报 ↗ |
| 2025-03-12 | Raheja Manohar K. | 买入 (P) | Common Stock | 10,000 | USD 2.73 | USD 27,300 | SEC 申报 ↗ |
| 2024-12-06 | Raheja Manohar K. | 买入 (P) | Common Stock | 5,000 | USD 3.85 | USD 19,250 | SEC 申报 ↗ |
| 2024-12-03 | Raheja Manohar K. | 买入 (P) | Common Stock | 3,376 | USD 3.89 | USD 13,133 | SEC 申报 ↗ |
Form 4 申报证据
60 transaction lines in the latest 365-day window; 244 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Taylor Brenton | 卖出 (S) | Common Stock | 2,988 | USD 8.85 | USD 26,453 | SEC 申报 ↗ |
| 2026-10-02 | Rodberg James | 卖出 (S) | Common Stock | 7,208 | USD 8.85 | USD 63,812 | SEC 申报 ↗ |
| 2026-10-02 | Bauerlein Alison | 卖出 (S) | Common Stock | 25,260 | USD 8.85 | USD 223,627 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Taylor Brenton | 卖出 (S) | Common Stock | 2,988 | USD 8.85 | USD 26,453 | SEC 申报 ↗ |
| 2026-10-02 | Rodberg James | 卖出 (S) | Common Stock | 7,208 | USD 8.85 | USD 63,812 | SEC 申报 ↗ |
| 2026-10-02 | Bauerlein Alison | 卖出 (S) | Common Stock | 25,260 | USD 8.85 | USD 223,627 | SEC 申报 ↗ |
| 2026-10-01 | Badawi Paul | 卖出 (S) | Common Stock | 29,653 | USD 9.05 | USD 268,330 | SEC 申报 ↗ |
| 2026-10-01 | Badawi David | 卖出 (S) | Common Stock | 7,797 | USD 9.05 | USD 70,555 | SEC 申报 ↗ |
| 2026-08-10 | Rashid Kashif | 奖励／授予 (A) | Common Stock | 181,818 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-06 | HAYDEN JEREMY B. | 卖出 (S) | Common Stock | 12,733 | USD 5.51 | USD 70,159 | SEC 申报 ↗ |
| 2026-07-06 | Badawi David | 卖出 (S) | Common Stock | 7,418 | USD 5.51 | USD 40,873 | SEC 申报 ↗ |
| 2026-07-02 | Rodberg James | 卖出 (S) | Common Stock | 6,902 | USD 5.36 | USD 36,995 | SEC 申报 ↗ |
| 2026-07-02 | Bauerlein Alison | 卖出 (S) | Common Stock | 24,184 | USD 5.36 | USD 129,626 | SEC 申报 ↗ |
| 2026-07-01 | Taylor Brenton | 卖出 (S) | Common Stock | 2,829 | USD 5.42 | USD 15,333 | SEC 申报 ↗ |
| 2026-07-01 | Badawi Paul | 卖出 (S) | Common Stock | 28,684 | USD 5.42 | USD 155,467 | SEC 申报 ↗ |
| 2026-06-10 | Encrantz Staffan | 买入 (P) | Common Stock | 14,100 | USD 4.88 | USD 68,808 | SEC 申报 ↗ |
| 2026-06-04 | Zurbay Donald | 奖励／授予 (A) | Common Stock | 28,261 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Mazzacco Catherine | 奖励／授予 (A) | Common Stock | 28,261 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Fountain Tamara | 奖励／授予 (A) | Common Stock | 28,261 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Encrantz Staffan | 奖励／授予 (A) | Common Stock | 28,261 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Burbach Gerhard F | 奖励／授予 (A) | Common Stock | 28,261 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-18 | Bauerlein Alison | 卖出 (S) | Common Stock | 12,728 | USD 5.12 | USD 65,167 | SEC 申报 ↗ |
| 2026-04-06 | Rodberg James | 卖出 (S) | Common Stock | 7,231 | USD 3.55 | USD 25,670 | SEC 申报 ↗ |
| 2026-04-06 | HAYDEN JEREMY B. | 卖出 (S) | Common Stock | 13,761 | USD 3.55 | USD 48,852 | SEC 申报 ↗ |
| 2026-04-02 | Bauerlein Alison | 卖出 (S) | Common Stock | 25,874 | USD 3.48 | USD 90,042 | SEC 申报 ↗ |
| 2026-04-02 | Badawi David | 卖出 (S) | Common Stock | 8,168 | USD 3.48 | USD 28,425 | SEC 申报 ↗ |
| 2026-04-01 | Taylor Brenton | 卖出 (S) | Common Stock | 2,869 | USD 3.70 | USD 10,615 | SEC 申报 ↗ |
| 2026-04-01 | Badawi Paul | 卖出 (S) | Common Stock | 29,244 | USD 3.70 | USD 108,203 | SEC 申报 ↗ |
| 2026-02-19 | Badawi David | 期权行权／转换 (M) | Common Stock | 21,270 | USD 0.23 | USD 4,892 | SEC 申报 ↗ |
| 2026-02-03 | Taylor Brenton | 奖励／授予 (A) | Common Stock | 100,464 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-03 | Rodberg James | 奖励／授予 (A) | Common Stock | 86,940 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-03 | HAYDEN JEREMY B. | 奖励／授予 (A) | Common Stock | 115,920 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-03 | Bauerlein Alison | 奖励／授予 (A) | Common Stock | 127,512 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | SGHT |
| CIK | 0001531177 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 244 transaction lines from 2021-07-19 to 2026-10-02 44 P purchase lines · 89 S sale lines · 111 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.